PreveCeutical Medical Inc (18H) - Total Liabilities
Based on the latest financial reports, PreveCeutical Medical Inc (18H) has total liabilities worth €7.85 Million EUR (≈ $9.18 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PreveCeutical Medical Inc - Total Liabilities Trend (2016–2024)
This chart illustrates how PreveCeutical Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See 18H working capital ratio to evaluate short-term liquidity relative to the company's equity base.
PreveCeutical Medical Inc Competitors by Total Liabilities
The table below lists competitors of PreveCeutical Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Twin Vee Powercats Co
NASDAQ:VEEE
|
USA | $5.97 Million |
|
Grupo Vasconia S.A.B
MX:VASCONI
|
Mexico | MX$2.18 Billion |
|
Tarachi Gold Corp
F:4RZ
|
Germany | €3.22K |
|
REDSUN PROPERTIES GROUP
F:0RJ
|
Germany | €52.83 Billion |
|
Weaccess Group SA
PA:MLWEA
|
France | €1.16 Million |
|
BPH Global Ltd
AU:BP8
|
Australia | AU$2.01 Million |
|
Earthworks Industries Inc
V:EWK
|
Canada | CA$7.66 Million |
|
Usha Resources Ltd
V:USHA
|
Canada | CA$691.37K |
Liability Composition Analysis (2016–2024)
This chart breaks down PreveCeutical Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 18H stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 17.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PreveCeutical Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PreveCeutical Medical Inc (2016–2024)
The table below shows the annual total liabilities of PreveCeutical Medical Inc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €6.86 Million ≈ $8.02 Million |
+15.15% |
| 2023-12-31 | €5.96 Million ≈ $6.97 Million |
+23.54% |
| 2022-12-31 | €4.82 Million ≈ $5.64 Million |
+13.11% |
| 2021-12-31 | €4.27 Million ≈ $4.99 Million |
+9.19% |
| 2020-12-31 | €3.91 Million ≈ $4.57 Million |
-26.91% |
| 2019-12-31 | €5.34 Million ≈ $6.25 Million |
+27.64% |
| 2018-12-31 | €4.19 Million ≈ $4.90 Million |
+42.23% |
| 2017-12-31 | €2.94 Million ≈ $3.44 Million |
+485.00% |
| 2016-12-31 | €503.24K ≈ $588.35K |
-- |
About PreveCeutical Medical Inc
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disor… Read more